COEPW
Z Squared Inc.Price
Daily candles with volume.
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q1 2026: 1 added (0 new), 0 trimmed or exited.
Who's buying
13F· Q1 2026| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $279.00 |
| Walleye Trading LLC | TRIM | $2.1K |
| BANK OF AMERICA CORP /DE/ | TRIM | $2.00 |
| Walleye Trading LLC | ADD | $3.0K |
| UBS Group AG | DOUBLED | $15.00 |
| BANK OF AMERICA CORP /DE/ | TRIM | $8.00 |
| WELLS FARGO & COMPANY/MN | TRIM | $2.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current FY | — | — | — | $0.00 |
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
SecBot reports
3 filings · 0 bullish · 0 bearish · 1 mixed · 2 neutral- NEUTRAL 3Apr 29, 2026
Christopher Ryan Schadel filed an initial statement of beneficial ownership (Form 3) with the SEC…
Routine insider onboarding filing with no trading activity or ownership data. No immediate action required; monitor future Form 4 filings for any insider transactions.
- NEUTRAL 25-NSEApr 24, 2026
Nasdaq has filed a Form 25-NSE to delist the warrants of Coeptis Therapeutics Holdings, Inc…
No trading action required for common stock holders; warrant holders should confirm final exercise dates and settlement terms. Monitor COEP common shares for any related corporate actions, though…
- MIXED 8-KApr 7, 2026
Coeptis Therapeutics announced that Nasdaq has approved, subject to customary conditions, the…
Traders should monitor for the closing of the merger in Q2 2026, which will result in a ticker change from COEP/COEPW to ZSQR and a strategic shift from biopharmaceuticals to cryptocurrency mining…
All COEPW filing & press-release reports (3)
- 3 reportApr 29, 2026
- 25-NSE reportApr 24, 2026
- 8-K reportApr 7, 2026